About Us
The University Health Network Toronto Transplant Institute (TTI) is the largest transplant program in Canada and one of the largest in the world. It performs over 650 solid organ transplants per year and provides long term care for over 5000 transplant recipients, and has one of the most active education and training and research programs in the world.
Veritas Therapeutics Inc. was established to bridge the gap from basic research findings to commercial products. We are located in an Industrial BioDevelopment Laboratory (IBDL) in the Toronto Medical Discovery Tower in the heart of Canada's Biotechnology centre. The infrastructure available includes a state of the art bioprocessing and bioanalytical laboratory capable of producing proof of principle biodiagnostic and biotherapeutic products.
Veritas is primarily an immunologic based company developing therapies for the treatment of Viral Hepatitis, Cancer, Autoimmune Disease, and Transplantation. Our lead program builds on the discovery of the novel immunosuppressive molecule FGL2 and its cognate receptor FCγR2B/Riii which are critical to the pathogenesis of important human inflammatory diseases.
Veritas Therapeutics Inc. was established to bridge the gap from basic research findings to commercial products. We are located in an Industrial BioDevelopment Laboratory (IBDL) in the Toronto Medical Discovery Tower in the heart of Canada's Biotechnology centre. The infrastructure available includes a state of the art bioprocessing and bioanalytical laboratory capable of producing proof of principle biodiagnostic and biotherapeutic products.
Veritas is primarily an immunologic based company developing therapies for the treatment of Viral Hepatitis, Cancer, Autoimmune Disease, and Transplantation. Our lead program builds on the discovery of the novel immunosuppressive molecule FGL2 and its cognate receptor FCγR2B/Riii which are critical to the pathogenesis of important human inflammatory diseases.